These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23082177)

  • 21. Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles.
    Taghdisi SM; Danesh NM; Lavaee P; Emrani AS; Hassanabad KY; Ramezani M; Abnous K
    Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():753-61. PubMed ID: 26838906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient synthesis of a maghemite/gold hybrid nanoparticle system as a magnetic carrier for the transport of platinum-based metallotherapeutics.
    Štarha P; Smola D; Tuček J; Trávníček Z
    Int J Mol Sci; 2015 Jan; 16(1):2034-51. PubMed ID: 25603182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel hydrophilic drug polymer nano-conjugates of Cisplatin showing long blood retention profile: its release kinetics, cellular uptake and bio-distribution.
    Verma AK; Sachin K
    Curr Drug Deliv; 2008 Apr; 5(2):120-6. PubMed ID: 18393814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stabilizing gold nanoparticle bioconjugates in physiological conditions by PEGylation.
    Comenge J; Puntes VF
    Methods Mol Biol; 2013; 1025():281-9. PubMed ID: 23918346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
    Lee SM; O'Halloran TV; Nguyen ST
    J Am Chem Soc; 2010 Dec; 132(48):17130-8. PubMed ID: 21077673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting and delivering platinum anticancer drugs using fluorescent maghemite nanoparticles.
    Wang J; Wang X; Song Y; Zhu C; Wang J; Wang K; Guo Z
    Chem Commun (Camb); 2013 Apr; 49(27):2786-8. PubMed ID: 23439956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
    Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
    J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic/Pharmacodynamics Modeling of Drug-Loaded PLGA Nanoparticles Targeting Heterogeneously Vascularized Tumor Tissue.
    Miller HA; Frieboes HB
    Pharm Res; 2019 Nov; 36(12):185. PubMed ID: 31773287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates.
    Cheng Y; Meyers JD; Broome AM; Kenney ME; Basilion JP; Burda C
    J Am Chem Soc; 2011 Mar; 133(8):2583-91. PubMed ID: 21294543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of a Novel Theranostic Nanomedicine (III): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene.
    Patil BR; Kang SY; Jung DH; Avaji PG; Jun YJ; Lee HJ; Sohn YS
    Int J Nanomedicine; 2020; 15():981-990. PubMed ID: 32103951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The systematic evaluation of size-dependent toxicity and multi-time biodistribution of gold nanoparticles.
    Li X; Hu Z; Ma J; Wang X; Zhang Y; Wang W; Yuan Z
    Colloids Surf B Biointerfaces; 2018 Jul; 167():260-266. PubMed ID: 29677597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
    Luo YL; Shiao YS; Huang YF
    ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacy.
    Paraskar A; Soni S; Basu S; Amarasiriwardena CJ; Lupoli N; Srivats S; Roy RS; Sengupta S
    Nanotechnology; 2011 Jul; 22(26):265101. PubMed ID: 21576779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin-incorporated nanoparticles of poly(acrylic acid-co-methyl methacrylate) copolymer.
    Lee KD; Jeong YI; Kim DH; Lim GT; Choi KC
    Int J Nanomedicine; 2013; 8():2835-45. PubMed ID: 23966778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gold Nanoparticles for the Delivery of Cancer Therapeutics.
    Connor DM; Broome AM
    Adv Cancer Res; 2018; 139():163-184. PubMed ID: 29941104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the pH Dependent Cytotoxicity of Paclitaxel Conjugated Gold Nanoparticles.
    Alhalili Z; Shapter J; Auliya NH; Sandersonb B
    Pharm Nanotechnol; 2017; 5(2):111-118. PubMed ID: 28440201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-Stimuli-Responsive Multifunctional Gd
    Kuang Y; Zhang Y; Zhao Y; Cao Y; Zhang Y; Chong Y; Pei R
    ACS Appl Mater Interfaces; 2020 Aug; 12(32):35928-35939. PubMed ID: 32686939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.